CTCF regulates wild-type and recombinant AAV gene expression by shaping viral chromatin
PLOS Pathogens · 13.11.2026 · 22 (11) · e1014342
DOI: 10.1371/journal.ppat.1014342 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 13.11.2026. Verfasst von Clairine I S Larsen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Virology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Wisconsin Partnership Program, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Adeno-Associated Viruses (AAVs) are powerful platforms for delivering therapeutic transgenes via recombinant AAV (rAAV) vectors. However, a limited understanding of the regulation of AAV gene expression has narrowed the ability to efficiently express therapeutic transgenes from rAAV vectors. Since rAAVs retain only the wtAAV inverted terminal repeats (ITR), we hypothesized that regulatory elements outside the ITR that govern wild-type AAV (wtAAV) gene expression can be used to modify rAAV genomes to enhance vector performance. Through in silico analysis, biochemical pulldowns, and high-throughput sequencing, we have identified that the host architectural protein CCCTC-binding Factor (CTCF) associates with the wtAAV type 2 (wtAAV2) genome but is absent from rAAV vectors. Global knockdown and site-specific deletion revealed that the CTCF binding element (CBE) on the wtAAV2 genome, located upstream of the viral P5 promoter, regulates expression of the viral Rep68/78 genes. We have re-engineered new rAAV vectors expressing a GFP reporter transgene to contain the wtAAV2-CBE upstream of the vector promoter. Our results show that CTCF binding dramatically increased rAAV transduction efficiency and GFP expression by up to four-fold across multiple cell types. This enhancement was independent of the AAV capsid serotype used for packaging rAAV vectors. CUT&RUN analysis revealed that this CBE was necessary and sufficient to regulate the chromatin landscape of wtAAV2 and rAAV2. Finally, we observed that CTCF-mediated chromatin remodeling of rAAV2 led to increased production of nascent RNA transcripts from the vector genome. Based on our findings, we propose that CTCF supports wtAAV2/rAAV gene expression by shaping the local chromatin landscape.
Autor:innen und Institutionen
- Institute for Molecular Virology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
- McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
- Ultragenyx Pharmaceuticals, Somerville, Massachusetts, United States of America.
- Department of Comparative Biosciences, University of Wisconsin School of Veterinary Medicine, Madison, Wisconsin, United States of America.
- McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
- Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
ORCID-Profile: Matthew S Fuller, Kinjal Majumder
Förderung
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Wisconsin Partnership Program
- National Institute of General Medical Sciences
- National Science Foundation Graduate Research Fellowship Program
- SciMED Graduate Research Scholarship
- Ultragenyx Pharmaceuticals
- Research to Prevent Blindness, Inc.
- Sandra Lemke Trout Chair in Eye Research
Zitieren
APA
Larsen, C. I. S., Abrahams, R. R., Guertler, R., Wilion, E. M., Erata, E., Sykes, Z. H., Stoica, L. I., Thirumoorthy, G., Sinha, D., Rai, R., Majumder, J., Hofer, E. K., Hart, E., Dissanayake, E., Gern, J. E., Gamm, D. M., Murphy, W. L., Fuller, M. S., & Majumder, K. (2026). CTCF regulates wild-type and recombinant AAV gene expression by shaping viral chromatin. PLOS Pathogens, 22(11), e1014342. https://doi.org/10.1371/journal.ppat.1014342
Vancouver
Larsen CIS, Abrahams RR, Guertler R, Wilion EM, Erata E, Sykes ZH, et al. CTCF regulates wild-type and recombinant AAV gene expression by shaping viral chromatin. PLOS Pathogens. 2026;22(11):e1014342. doi:10.1371/journal.ppat.1014342
BibTeX
@article{Larsen2026,
author = {Larsen, Clairine I S and Abrahams, Rhiannon R and Guertler, Rea and Wilion, Elliott M and Erata, Eda and Sykes, Zachary H and Stoica, Lorelei I and Thirumoorthy, Gopishankar and Sinha, Divya and Rai, Richa and Majumder, Joydeb and Hofer, Elizabeth K and Hart, Eleanor and Dissanayake, Eishika and Gern, James E and Gamm, David M and Murphy, William L and Fuller, Matthew S and Majumder, Kinjal},
title = {CTCF regulates wild-type and recombinant AAV gene expression by shaping viral chromatin},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {11},
pages = {e1014342},
doi = {10.1371/journal.ppat.1014342}
}
EUVIMED